Point72 Middle East FZE’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-12,755	Closed	-$89.8K	–	932
2023 Q2	$89.8K	Sell	12,755 -2,300	-15%	-$16.2K	﹤0.01%	708
2023 Q1	$126K	Buy	+15,055	New	+$126K	﹤0.01%	553